middle.news
Orthocell’s Remplir gains traction across the US and Thailand
8:57am on Thursday 22nd of October, 2026 AEDT
•
Medical Technology
Read Story
Orthocell’s Remplir gains traction across the US and Thailand
8:57am on Thursday 22nd of October, 2026 AEDT
Key Points
US Remplir unit sales rose 25% to 149 in the September quarter
Global Remplir revenue increased 20% quarter on quarter and exceeded 40% of total revenue
Adoption expanded to 79 US hospitals and 93 surgeons
First Remplir sales were recorded in Thailand
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE